Nicholas Saraceno

A nonprofit advocacy group and several supplement companies argue that statements published on government health agency websites should qualify as the basis for new disease-risk reduction claims, a position the FDA has long rejected for supplements specifically.

Sonoran University of Health Sciences will honor the United Natural Products Alliance founder for more than four decades of work that helped establish the regulatory framework still governing dietary supplements today.

Mike DeMarco, wellness coach with MJH Life Sciences, has built his foundation around protein, creatine, and a multivitamin for years, but it's the mindset reinforcement that keeps him coming back to them.

From cutting volume to building a race-specific running base, Mike DeMarco breaks down how he restructured his training for HYROX, and why the lessons apply well beyond the race format.

The launch signals supplement brands moving into a growing segment of the protein market defined by water-mixability and low-calorie profiles.

L Catterton's lead investment in a dermatologist-built skincare brand signals continued institutional appetite for science-backed personal care, with implications for how finished product manufacturers are positioning clinical credibility in the consumer market.

With 7 US states having enacted packaging extended producer responsibility laws and more on the horizon, a new cross-industry guidance document offers a standardized approach to the packaging data management requirements that are proving to be a significant operational challenge for finished product companies.

Emerging science presented at a major NAD+ metabolism conference is shifting attention from simply raising NAD+ levels toward preserving them, and botanical approaches targeting the CD38 enzyme are at the center of that discussion.

The appointment of a finance executive with deep investment banking and growth equity experience signals a shift toward a more capital-intensive phase for the Austin-based wellness ingredient supplier.

A randomized controlled trial in patients with established coronary artery disease found that daily MK-7 supplementation was associated with nearly one-third less progression of coronary artery calcification compared with placebo over 24 months.

In the latest episode, Nicholas Saraceno discusses emerging evidence linking premature menopause to cardiovascular risk, while exploring why experts are calling for more targeted clinical research in menopause-focused nutrition products.

From S-equol to bioactive collagen peptides, a session at The Outlook on Women's Wellness conference mapped the clinical evidence and practical formulation considerations for a growing class of bone-supportive ingredients.

A UK Biobank analysis of more than 272,000 participants challenges the narrative that omega-6 fatty acids promote obesity.

A state-level enforcement probe citing third-party testing data, and the industry's methodological objections to that data, raise compliance and quality control questions for finished product manufacturers.

As creatine innovation evolves beyond traditional gym performance, manufacturers are developing clinically supported formats aimed at brain energy metabolism, cellular resilience, healthy aging, and GLP-1-associated muscle preservation.

The FSA and FSS authorization of a standardized tetrahydrocurcuminoids ingredient for use in food supplements expands the market access case for a curcumin derivative with a distinct stability and bioavailability profile.

Voluntary pledges from accreditors and medical schools to increase nutrition education may gradually shift how physicians engage with diet-based and supplement interventions.

The development underscores continued innovation in plant-based sweetener development and regulatory review.

A new PLT Health Solutions-Alethios collaboration focused on decentralized clinical research reflects growing demand among nutraceutical manufacturers for product-specific evidence.

The veteran consumer packaged goods executive is now at the helm of one of Canada's largest natural health product distributors as the sector continues to evolve.

The new lion’s mane mycelium ingredient from Nammex enters the cognitive health category with a focus on analytical verification and standardized erinacine A content.

New research examining the taste chemistry of Chardonnay grape marc suggests that whole-food ingredient systems may influence bitterness, astringency, and formulation complexity.

New clinical findings involving Lactiplantibacillus plantarum 299v reflect growing interest in population-specific probiotic validation and microbiome research across Asian markets.

From mitochondrial health and omega-3s to PMOS, botanicals, and preconception nutrition, emerging research is reshaping how the natural products industry approaches fertility and women’s health.

In an interview with Nutritional Outlook, Sameena Rahman, MD, a board-certified OB/GYN, discusses why the shift from Polycystic Ovary Syndrome to Polyendocrine Metabolic Ovarian Syndrome reflects growing recognition of the condition’s links to insulin resistance, inflammation, cardiovascular risk, and lifelong metabolic health.

From hormonal wellness and sports recovery to delivery technologies and Ayurvedic positioning, fenugreek is gaining attention across multiple women’s health categories as manufacturers explore multifunctional botanical formulations.

The company’s 2025 sustainability report outlines progress in sustainable crop sourcing, ingredient circularity, and agricultural waste reduction as food and nutraceutical manufacturers continue emphasizing supply chain resilience and environmental accountability.

A new collaboration between Lallemand Health Solutions and Université Laval will explore how microbiome-targeted interventions may support healthy aging, immune function, and metabolic health as demand for evidence-backed longevity solutions continues growing across the nutraceutical industry.

New funding and recent FDA approval activity are highlighting a growing industry interest in fermentation-derived natural colors.

In the debut episode, Nicholas Saraceno discusses emerging research on histamine intolerance, including the microbiome’s potential role, limitations surrounding DAO testing, and why diagnosis remains controversial.